Pay in 4 interest-free payments of $28.75 Learn more
Ships within 48 hours · Estimated delivery Sep 16 - Sep 21
NLG919 was dosed to mice orally or through IP injection with different dose and schedule
InChiKey: XLTFNNCXVBYBSX-UHFFFAOYSA-N
The induction of angiogenesis by bFGF is significantly inhibited by oral treatment of Lenalidomide in a dose-dependent manner
Smiles: CC(C)(C)OC1C=CC(=CC=1)OCC1CC2=CC=CC=C2CN1C(=O)C1=CC=CC2=CC=CC=C21
removal of SNS-032 reactivates RNA polymerase II
NB-598 Hydrochloride alafenamide hemifumarate NLG919 was dosed to miceNB 598 is a potent competitive inhibitor of squalene epoxidase (SE). NB 598 suppresses triglyceride biosynthesis through the farnesol pathway. NB 598 suppresses the secretion of cholesterol and triacylglycerol and simultaneously reduces apolipoprotein B in HepG2 cells. NB 598 reduced basolaterally secreted radioactivity in cholesterol, cholesterol ester, PL and TG. Furthermore, NB 598 suppressed the basolateral secretion of apolipoprotein (apo) B.
US$ 691.00
US$ 928.50
US$ 821.50
US$ 2738.50
US$ 915.00
US$ 992.50
US$ 107574.50
US$ 2224.50
US$ 2044.00
US$ 992.50
US$ 1724.50
US$ 4916.00
US$ 1023.00
US$ 992.50
US$ 1023.00
US$ 974.50